Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology

• Publication date

  1995-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00042560-199509000-00008PMID 7648285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection.

  1994cited by this paper
• Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.

  1994cited by this paper
• Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.

  1994cited by this paper
• Effect of antacids in didanosine tablet on bioavailability of isoniazid

  1994cited by this paper
• Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection.

  1994cited by this paper
• Combination Therapy with Zidovudine and Didanosine Compared with Zidovudine Alone in HIV-1 Infection

  1993cited by this paper
• Effect of Time of Food Administration on the Bioavailability of Didanosine From a Chewable Tablet Formulation

  1993cited by this paper
• Metabolism of didanosine (ddI) by erythrocytes: pharmacokinetic implications.

  1993cited by this paper
• Variation of Cmax and Cmax/AUC in investigations of bioequivalence.

  1993cited by this paper
• Logarithmic transformation in bioequivalence: application with two formulations of perphenazine.

  1993cited by this paper
• Lack of pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and 3'-azido-3'-deoxythymidine in rats

  1992cited by this paper
• HIV-1 sensitivity to zidovudine and clinical outcome in children.

  1992cited by this paper
• Bias and variance of extrapolated tails for area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC)

  1992cited by this paper
• A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.

  1992cited by this paper
• Pharmacokinetic Evaluation of Drug Interactions with Anti-HIV Drugs, II: Effect of 2′,3′-Dideoxyinosine (ddI) on Zidovudine Kinetics in Monkeys

  1992cited by this paper
• Clinical pharmacokinetics of 3′‐azido‐3′‐deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3′‐amino‐3′‐deoxythymidine

  1992cited by this paper
• Pharmacokinetics of 2′, 3′‐dideoxyadenosine and 2′, 3′‐dideoxyinosine in patients with severe human immunodeficiency virus infection

  1990cited by this paper
• Probenecid Inhibits the Metabolic and Renal Clearances of Zidovudine (AZT) in Human Volunteers

  1990cited by this paper
• Quantitation of didanosine in human plasma and urine by high-performance liquid chromatography.

  1990cited by this paper
• A distribution-free procedure for the statistical analysis of bioequivalence studies.

  1990cited by this paper
• Azidothymidine steady-state pharmacokinetics in patients with AIDS and AIDS-related complex.

  1989cited by this paper
• Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography.

  1988cited by this paper
• The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

  1987cited by this paper

• Therapeutic implications of renal anionic drug transporters.

  2010cites this paper
• Nucleoside reverse transcriptase inhibitors and their phosphorylated metabolites in human immunodeficiency virus-infected human matrices.

  2008cites this paper
• Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV Infection

  1999cites this paper
• Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.

  1999cites this paper
• Pharmacokinetic interaction between ritonavir and didanosine when administered concurrently to HIV-infected patients.

  1998cites this paper
• Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients

  1997cites this paper
• New Drug Interactions with Zidovudine

  1997cites this paper
• Phase I Dose‐Escalation Pharmacokinetics of AZT‐P‐ddI (IVX‐E‐59) in Patients with Human Immunodeficiency Virus

  1997cites this paper